The ABCC3 efflux pump, in the case of breast cancer cells, is associated with HER2 positive cells, which is the case of BT-747 cells [49], and has been associated to a decreased rate of drug retention and with chemoresistance [73]. This evidence concerns the gene ERBB2 and breast cancer.